DC-SIGN (CD209) promoter -336 A/G (rs4804803) polymorphism associated with susceptibility of Kawasaki disease

Hong Ren Yu, Wei Pin Chang, Lin Wang, Ying Jui Lin, Chi Di Liang, Kuender D. Yang, Chiu Ming Kuo, Yi Chuan Huang, Wei-Chiao Chang, Ho Chang Kuo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Kawasaki disease (KD) is characterized by systemic vasculitis of unknown etiology. High-dose intravenous immunoglobulin (IVIG) is the most effective therapy for KD to reduce the prevalence of coronary artery lesion (CAL) formation. Recently, the 2, 6 sialylated IgG was reported to interact with a lectin receptor, specific intracellular adhesion molecule-3 grabbing nonintegrin homolog-related 1 (SIGN-R1) in mice and dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN) in human, and to trigger an anti-inflammatory cascade. This study was conducted to investigate whether the polymorphism of DC-SIGN (CD209) promoter -336 A/G (rs4804803) is responsible for susceptibility and CAL formation in KD patients using Custom TaqMan SNP Genotyping Assays. A total of 521 subjects (278KD patients and 243 controls) were investigated to identify an SNP of rs4804803, and they were studied and showed a significant association between the genotypes and allele frequency of rs4804803 in control subjects and KD patients (P=0.004 under the dominant model). However, the promoter variant of DC-SIGN gene was not associated with the occurrence of IVIG resistance, CAL formation in KD. The G allele of DC-SIGN promoter -336 (rs4804803) is a risk allele in the development of KD.

Original languageEnglish
Article number634835
JournalScientific World Journal
Volume2012
DOIs
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Mucocutaneous Lymph Node Syndrome
Cell Adhesion Molecules
Polymorphism
adhesion
Dendritic Cells
polymorphism
lesion
Coronary Vessels
allele
Intravenous Immunoglobulins
Single Nucleotide Polymorphism
Alleles
Mitogen Receptors
Systemic Vasculitis
etiology
Gene Frequency
Assays
genotype
Anti-Inflammatory Agents
Adhesion

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Environmental Science(all)
  • Medicine(all)

Cite this

DC-SIGN (CD209) promoter -336 A/G (rs4804803) polymorphism associated with susceptibility of Kawasaki disease. / Yu, Hong Ren; Chang, Wei Pin; Wang, Lin; Lin, Ying Jui; Liang, Chi Di; Yang, Kuender D.; Kuo, Chiu Ming; Huang, Yi Chuan; Chang, Wei-Chiao; Kuo, Ho Chang.

In: Scientific World Journal, Vol. 2012, 634835, 2012.

Research output: Contribution to journalArticle

Yu, Hong Ren ; Chang, Wei Pin ; Wang, Lin ; Lin, Ying Jui ; Liang, Chi Di ; Yang, Kuender D. ; Kuo, Chiu Ming ; Huang, Yi Chuan ; Chang, Wei-Chiao ; Kuo, Ho Chang. / DC-SIGN (CD209) promoter -336 A/G (rs4804803) polymorphism associated with susceptibility of Kawasaki disease. In: Scientific World Journal. 2012 ; Vol. 2012.
@article{e41c6d07d26e4d5c82dbca247d76e128,
title = "DC-SIGN (CD209) promoter -336 A/G (rs4804803) polymorphism associated with susceptibility of Kawasaki disease",
abstract = "Kawasaki disease (KD) is characterized by systemic vasculitis of unknown etiology. High-dose intravenous immunoglobulin (IVIG) is the most effective therapy for KD to reduce the prevalence of coronary artery lesion (CAL) formation. Recently, the 2, 6 sialylated IgG was reported to interact with a lectin receptor, specific intracellular adhesion molecule-3 grabbing nonintegrin homolog-related 1 (SIGN-R1) in mice and dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN) in human, and to trigger an anti-inflammatory cascade. This study was conducted to investigate whether the polymorphism of DC-SIGN (CD209) promoter -336 A/G (rs4804803) is responsible for susceptibility and CAL formation in KD patients using Custom TaqMan SNP Genotyping Assays. A total of 521 subjects (278KD patients and 243 controls) were investigated to identify an SNP of rs4804803, and they were studied and showed a significant association between the genotypes and allele frequency of rs4804803 in control subjects and KD patients (P=0.004 under the dominant model). However, the promoter variant of DC-SIGN gene was not associated with the occurrence of IVIG resistance, CAL formation in KD. The G allele of DC-SIGN promoter -336 (rs4804803) is a risk allele in the development of KD.",
author = "Yu, {Hong Ren} and Chang, {Wei Pin} and Lin Wang and Lin, {Ying Jui} and Liang, {Chi Di} and Yang, {Kuender D.} and Kuo, {Chiu Ming} and Huang, {Yi Chuan} and Wei-Chiao Chang and Kuo, {Ho Chang}",
year = "2012",
doi = "10.1100/2012/634835",
language = "English",
volume = "2012",
journal = "The Scientific World Journal",
issn = "2356-6140",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - DC-SIGN (CD209) promoter -336 A/G (rs4804803) polymorphism associated with susceptibility of Kawasaki disease

AU - Yu, Hong Ren

AU - Chang, Wei Pin

AU - Wang, Lin

AU - Lin, Ying Jui

AU - Liang, Chi Di

AU - Yang, Kuender D.

AU - Kuo, Chiu Ming

AU - Huang, Yi Chuan

AU - Chang, Wei-Chiao

AU - Kuo, Ho Chang

PY - 2012

Y1 - 2012

N2 - Kawasaki disease (KD) is characterized by systemic vasculitis of unknown etiology. High-dose intravenous immunoglobulin (IVIG) is the most effective therapy for KD to reduce the prevalence of coronary artery lesion (CAL) formation. Recently, the 2, 6 sialylated IgG was reported to interact with a lectin receptor, specific intracellular adhesion molecule-3 grabbing nonintegrin homolog-related 1 (SIGN-R1) in mice and dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN) in human, and to trigger an anti-inflammatory cascade. This study was conducted to investigate whether the polymorphism of DC-SIGN (CD209) promoter -336 A/G (rs4804803) is responsible for susceptibility and CAL formation in KD patients using Custom TaqMan SNP Genotyping Assays. A total of 521 subjects (278KD patients and 243 controls) were investigated to identify an SNP of rs4804803, and they were studied and showed a significant association between the genotypes and allele frequency of rs4804803 in control subjects and KD patients (P=0.004 under the dominant model). However, the promoter variant of DC-SIGN gene was not associated with the occurrence of IVIG resistance, CAL formation in KD. The G allele of DC-SIGN promoter -336 (rs4804803) is a risk allele in the development of KD.

AB - Kawasaki disease (KD) is characterized by systemic vasculitis of unknown etiology. High-dose intravenous immunoglobulin (IVIG) is the most effective therapy for KD to reduce the prevalence of coronary artery lesion (CAL) formation. Recently, the 2, 6 sialylated IgG was reported to interact with a lectin receptor, specific intracellular adhesion molecule-3 grabbing nonintegrin homolog-related 1 (SIGN-R1) in mice and dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN) in human, and to trigger an anti-inflammatory cascade. This study was conducted to investigate whether the polymorphism of DC-SIGN (CD209) promoter -336 A/G (rs4804803) is responsible for susceptibility and CAL formation in KD patients using Custom TaqMan SNP Genotyping Assays. A total of 521 subjects (278KD patients and 243 controls) were investigated to identify an SNP of rs4804803, and they were studied and showed a significant association between the genotypes and allele frequency of rs4804803 in control subjects and KD patients (P=0.004 under the dominant model). However, the promoter variant of DC-SIGN gene was not associated with the occurrence of IVIG resistance, CAL formation in KD. The G allele of DC-SIGN promoter -336 (rs4804803) is a risk allele in the development of KD.

UR - http://www.scopus.com/inward/record.url?scp=84862330847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862330847&partnerID=8YFLogxK

U2 - 10.1100/2012/634835

DO - 10.1100/2012/634835

M3 - Article

VL - 2012

JO - The Scientific World Journal

JF - The Scientific World Journal

SN - 2356-6140

M1 - 634835

ER -